Izraelis - hebrajų - Ministry of Health

perrigo israel pharmaceuticals ltd - granisetron as hydrochloride - solution for injection - granisetron - for the treatment of nausea and vomiting associated with antineoplastic therapy.

Izraelis - hebrajų - Ministry of Health

teva pharmaceutical indust.ltd - granisetron as hydrochloride 3 mg / 3 ml - solution for infusion - granisetron - for the prevention and control of nausea and vomiting induced by cytostatic therapy (chemotherapy and radiotherapy).

Izraelis - hebrajų - Ministry of Health

teva pharmaceutical indust.ltd - palonosetron as hydrochloride 0.05 mg / 1 ml - solution for injection - palonosetron - prevention of chemotherapy - induced nausea and vomiting (cinv).

Izraelis - hebrajų - Ministry of Health

bioavenir ltd - lactulose 66.7 g / 100 ml - solution (oral) - lactulose - chronic constipation. acute and chronic hepatic encephalopathy.

Izraelis - hebrajų - Ministry of Health

bioavenir ltd - lactulose 66.7 g / 100 ml - solution (oral) - lactulose - chronic constipation. acute and chronic hepatic encephalopathy.

Izraelis - hebrajų - Ministry of Health

novo nordisk ltd - insulin aspart 100 u/ml - solution for injection - penfill - insulin aspart - treatment of patients with diabetes mellitus.

Izraelis - hebrajų - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Izraelis - hebrajų - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Izraelis - hebrajų - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.

Izraelis - hebrajų - Ministry of Health

astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.